Do GLP-1 patches, drops and supplements work?
What is inside the patches, drops and powders sold with "GLP-1" in the name, what regulators found when they tested them, and what Indian rules say.
Written for India. Reading from elsewhere? Other country versionsComing soon
No, not on current evidence. We found no published trial showing weight loss from a product sold as a GLP-1 patch, drop or supplement. When Australia's drug regulator tested such products in 2026, it found no GLP-1 medicine in them. Real GLP-1 medicines in India are prescription injections or tablets.
Key takeaways
- Products sold as GLP-1 patches, drops or supplements have no published trial showing weight loss that we could find, and a 2026 review of 24 patches found no posted lab tests.1
- Australia's drug regulator tested imported products labelled as GLP-1 in 2026, including a microneedle patch and drops, and found no GLP-1 medicine in them.2
- Even a real semaglutide tablet needs a special absorption helper, and only about 0.4% to 1% of each Rybelsus tablet reaches the blood.3
- India's health supplement rules say supplements cannot contain a drug, cannot claim to treat a disease, and must say "NOT FOR MEDICINAL USE".6
- In October 2026, India's food regulator FSSAI sent notices over a supplement whose name and claims tied it to GLP-1 treatment.7
On this page
- What are GLP-1 patches, drops and supplements?
- Can a GLP-1 medicine work as a patch or drops?
- What did regulators find when they tested them?
- What does Indian law say about these products?
- Is berberine a "natural GLP-1"?
- Are they safe to try?
- How can you tell a GLP-1 medicine from a look-alike?
- Questions people ask
- How we researched this
- We describe types of product, not brands, and we don't link to any seller.
- GLP-1 medicines are prescription-only in India and cannot be bought over the counter.8
- If you want to know whether a real GLP-1 medicine could be an option, that is a question for a doctor: see Guide 4: should I consider one?
What are GLP-1 patches, drops and supplements?
They are products sold with "GLP-1" in the name or the advertising, but without a GLP-1 medicine approved as their ingredient. They come as skin patches, drops, liquids, capsules and powders.
A 2026 US review found 24 skin-patch products and one gel sold as "natural GLP-1".1 On average each listed 7 plant or nutrient ingredients. The most common were berberine, glutamine, cinnamon and pomegranate.1 None of the sellers posted a lab certificate showing what was inside.1
The products Australia's regulator tested in 2026 included a "microneedle" patch, drops, oral liquids and small glass ampoules to drink.2 A third group is food products, such as protein powders, sold with names or claims that link them to people on GLP-1 treatment.7
Can a GLP-1 medicine work as a patch or drops?
No approved GLP-1 medicine comes as a patch or drops. Even the approved tablet needs a special helper ingredient, and almost all of each tablet is lost.
Semaglutide is a large molecule, a chain of building blocks called a peptide. Its molecular weight is about 4,114, far bigger than most tablet medicines.5 Injected under the skin, about 89% of it reaches the blood.4
Swallowed, very little gets through. The Rybelsus tablet carries an absorption helper called SNAC, and still only about 0.4% to 1% of each tablet reaches the blood.3 That is why the tablet is taken daily, on an empty stomach, at a far higher dose than the weekly injection.3 A patch or a few drops has no such helper on its label. The products in the US review listed plant and nutrient ingredients, not a GLP-1 medicine.1
How the real medicines work is in what GLP‑1 medicines do, and the tablets in Is there an Ozempic tablet?
What did regulators find when they tested them?
Australia's drug regulator, the TGA, tested imported products labelled as GLP-1 and found no GLP-1 medicine in any of them.
Its safety advisory of 2 March 2026 says lab testing "confirmed that the products contain no GLP-1 or any GLP-1 analogues, despite being labelled as such".2 The list included a microneedle patch and drops.2 The TGA warned that such products may contain undisclosed and harmful ingredients, and may "provide no medical benefit".2
That is an Australian test of imported products. We found no Indian lab test of GLP-1 patches or drops, but the same kinds of product are sold online worldwide.1,2
A 1-minute check against India's 2025 obesity guideline and the drug labels. It doesn't decide for you. No sign-up.
What does Indian law say about these products?
India's food regulator says a health supplement cannot contain a drug or claim to treat a disease. In October 2026 it acted against a supplement tied to GLP-1 treatment.
- Supplement rules. FSSAI's 2022 rules cover health supplements taken by mouth. They "shall not include a drug" and "shall not claim to treat, cure, mitigate or prevent any specific disease", unless the regulator permits it.6 Their labels must say "NOT FOR MEDICINAL USE".6
- The October 2026 notices. On 8 October 2026, FSSAI sent notices to a supplement maker and online sellers. The product was advertised as "high protein support for lean muscle preservation during GLP-1/GIP therapies".7 FSSAI said the name and claims created "a misleading association" with those therapies, and asked the companies to explain why it should not act.7
- Advertising law. The Drugs and Magic Remedies Act, 1954, bans advertising a drug for the diseases in its Schedule, which include obesity and diabetes.9
- GLP-1 medicines. On 10 March 2026, India's drug controller told drug makers to stop misleading advertisements that could lead people to use GLP-1 drugs without a prescription.8 How those rules work is in CDSCO's GLP-1 advertising rules.
Is berberine a "natural GLP-1"?
No. Berberine is a plant substance, not a GLP-1 medicine, and its effect on weight in studies was small.
A 2026 review of 23 studies found people lost 0.88 kg more on berberine than in the comparison groups.12 The authors asked for better trials, with blinding and checks on purity.12 The US government's complementary-health centre says the evidence on weight "is not conclusive".13
Herbal, Ayurvedic and homeopathic weight products are covered in Do Ayurvedic, Patanjali or homeopathic weight-loss medicines work?
Are they safe to try?
Nobody can say, because the contents are often unknown. The TGA warned that such imported products may hold undisclosed, harmful ingredients.2
- No proof of contents. None of the 24 patch sellers in the US review posted a lab certificate, and many used deceptive advertising.1
- Hidden ingredients. The TGA said products bought online or from overseas may "contain undisclosed and potentially harmful ingredients".2
- Lost time and money. The TGA said such products may "provide no medical benefit, even if labelled as a GLP-1 medicine".2
- Interactions. If you take other medicines, tell your doctor about any supplement, berberine included.13
Fake injections are a separate risk: fake Ozempic and Mounjaro pens shows how to check a pen.
How can you tell a GLP-1 medicine from a look-alike?
Read the small print, not the name. A real GLP-1 medicine names its active medicine and is sold only against a prescription.
- The medicine's name. A GLP-1 medicine lists semaglutide, tirzepatide, liraglutide or dulaglutide on the pack, not "GLP-1 support".3,5
- "NOT FOR MEDICINAL USE". These words mark an Indian health supplement, which may not contain a drug.6
- The prescription. GLP-1 drugs cannot be bought over the counter in India.8 Who may prescribe them is in who can prescribe GLP-1 medicines in India.
- The form. Approved semaglutide and tirzepatide products are injections, and for semaglutide, tablets.3,4,5
Questions people ask
Do GLP-1 patches work for weight loss?
We found no published trial showing they do. A 2026 US review of 24 patch products found mostly plant and nutrient ingredients, such as berberine and cinnamon, and no posted lab test of any product.1
Do GLP-1 patches contain semaglutide?
Not the ones Australia's regulator tested. In March 2026 it reported finding no GLP-1 medicine in imported products labelled as GLP-1, including a microneedle patch and drops.2
Are GLP-1 supplements the same as Ozempic?
No. Ozempic is semaglutide, a prescription medicine. India's rules for health supplements say they cannot include a drug and must carry the words "NOT FOR MEDICINAL USE".6
Is there a GLP-1 tablet in India?
Yes, but only on prescription. Rybelsus and some Indian generic tablets contain semaglutide and are approved for type 2 diabetes.10,11
Can you get a GLP-1 medicine without a prescription in India?
No. A government statement on 1 April 2026 said GLP-1 drugs cannot be bought over the counter in India.8
How we researched this
On 14 October 2026 we read the 2026 US review of transdermal "natural GLP-1" products, the TGA's March 2026 advisory (through an archived copy, as the live page timed out), FSSAI's 2022 supplement rules, the Drugs and Magic Remedies Act, the April 2026 government backgrounder and a dated report of FSSAI's October 2026 notices. Absorption figures come from the US Rybelsus and Ozempic labels.
We name no product or seller. We found no Indian lab test of GLP-1 patches or drops, and no published trial of any of these products for weight loss, but we may have missed unpublished work.
Before you move on
- We found no trial showing weight loss from GLP-1 patches, drops or supplements.
- Australia's regulator found no GLP-1 medicine in products labelled as GLP-1.
- Indian supplement rules say supplements cannot contain a drug or claim to treat a disease.
- Real GLP-1 medicines name semaglutide, tirzepatide or another molecule, and need a prescription.
More from the India blog
The monthly India update
An independent guide to GLP‑1 medicines. We don't sell medicines, take drug-company money or earn clinic commissions. Once a month: new brands, price changes, approvals and recalls. How we write
Sources
- White CM, Tai Z, Nuzi K. Transdermal "natural GLP-1" dietary supplements violate law and place patients at risk. Ann Pharmacother 2026;60(8):813–816 (24 patch products and 1 gel; average of 7 natural ingredients, most often berberine, glutamine/glutamate, cinnamon and pomegranate; "No certificates of analysis were posted"). US study. Authors declared no conflicts. DOI · PMID 41480958
- Therapeutic Goods Administration (Australia). Counterfeit weight loss products claiming to contain GLP-1. Safety advisory, 2 March 2026 ("TGA laboratory testing of several imported unregistered products has confirmed that the products contain no GLP-1 or any GLP-1 analogues, despite being labelled as such"; tested products include a microneedle patch, drops, oral liquids and oral ampoules; such products may "provide no medical benefit"). Link · archived copy
- Novo Nordisk. Rybelsus and Ozempic (semaglutide) tablets prescribing information, US label, revised January 2026: "co-formulated with SNAC which facilitates the absorption"; absolute bioavailability "0.4% to 1%" for Rybelsus (12.3); daily dosing on an empty stomach (2.1). PDF
- Novo Nordisk. Ozempic (semaglutide) injection prescribing information, US label, revised May 2026: "Absolute bioavailability of semaglutide is 89%" (12.3). PDF
- Novo Nordisk. Wegovy (semaglutide) prescribing information, US label, revised June 2026: description, molecular weight 4113.58 g/mol (11). PDF
- Food Safety and Standards Authority of India. Food Safety and Standards (Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, and Prebiotic and Probiotic Food) Regulations, 2022, Annexure 1: products "intended to be consumed orally"; "shall not include a drug as defined in ... the Drugs and Cosmetics Act"; "shall not claim to treat, cure, mitigate or prevent any specific disease, disorder or condition ... unless specifically permitted"; label statement "NOT FOR MEDICINAL USE". PDF
- ETV Bharat English Team. Report on FSSAI's notices over misleading protein claims; the headline names the companies, including online sellers, which we don't repeat ("advertised as 'high protein support for lean muscle preservation during GLP-1/GIP therapies'"; the brand name "was found to create a misleading association between the product and such therapies"; companies directed to explain why action should not be taken). 8 October 2026. Link
- Press Information Bureau (PIB Research). GLP-1 Drugs: Use, Risks, and Regulation ("they cannot be purchased over the counter"; advisory of 10 March 2026 to drug makers on misleading advertisements; 49 businesses audited). Government backgrounder, 1 April 2026. PDF
- Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954: section 3 (no advertisement of a drug for the diseases in the Schedule) and Schedule items 9 (diabetes) and 38 (obesity). Copy hosted by the Tamil Nadu Drugs Control Department. PDF
- Medical Dialogues (Parthika Patel). Novo Nordisk gets CDSCO panel nod for Rybelsus label update ("indicated for the treatment of type 2 diabetes mellitus"). 10 September 2025. Link
- BusinessToday. Report on the launch of an Indian maker's oral semaglutide tablets, approved by CDSCO for type 2 diabetes. 20 May 2026. Link
- Elahi Vahed I, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes 2026;50(1):53–73 (23 articles; weight −0.88 kg against control groups; calls for better blinding and purity reporting). DOI · PMID 41310257
- US National Center for Complementary and Integrative Health (NCCIH). Berberine and weight loss: what you need to know ("Some studies suggest that it might, but the evidence is not conclusive"). Link
Last checked 14 Oct 2026 · Next review due 14 Apr 2027 · Report an error
How this post was made. Written by the GLP Guidebook team from the sources above. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine or supplement. How we write